Human mesenchymal stem cells maintain transgene expression during expansion and differentiation

Molecular Therapy

Volumn 3, Issue 6, 2001, Pages 857-866

  Lee, Keunmyoung ^a   Majumdar, Manas K ^a,b   Buyaner, Diana ^a   Hendricks, J Kyle ^a   Pittenger, Mark F ^a   Mosca, Joseph D ^a  

^a OSIRIS THERAPEUTICS INC   (United States)

^b PFIZER INC   (United States)

Author keywords

Differentiation; Green fluorescent protein; Interleukin 3; Mesenchymal stem cell; NOD SCID mice; Retroviral transduction; Transgene expression

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 3; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; RETROVIRUS; SCID MOUSE; STEM CELL; TRANSGENE;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0034953215     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0327     Document Type: Article

References (74)

1. Osteogenic stem cell and the stromal system of bone and marrow
2. Regulation of hemopoiesis by bone marrow stromal cells and their products
3. + fraction of adult human bone marrow contains the osteogenic precursors
4. Fibroblast precursors in normal and irradiated mouse hematopoietic organs
5. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies
6. Stromal stem cells: Marrow-derived osteogenic precursors
7. Transplantation of bone marrow fibroblastoid stromal cells in mice via the intravenous route
8. Multilineage potential of adult human mesenchymal stem cells
9. Marrow stromal cells as stem cells nonhematopoietic tissues
10. Characterization of cells with osteogenic potential from human marrow
11. Human mesenchymal stem cells can be directed into chondrocytes, adipocytes and osteocytes
12. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow
13. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells
14. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair
15. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells
16. Retroviral gene transfer into primary hepatocytes: Implications for genetic therapy of liver-specific functions
17. Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes
18. Retroviruses: Delivery vehicle to the liver
19. Baculovirus-mediated gene transfer into mammalian cells
20. Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells
21. Complete correction of the enzymatic defect of type I Gaucher disease fibroblasts by retroviral-mediated gene transfer
22. Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human
23. Clonal gene therapy: Transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo
24. An alternative approach to somatic cell gene therapy
25. Cells engineered to produce acetylcholine: Therapeutic potential for Alzheimer's disease
26. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum
27. Transfection with aFGF cDNA improves wound healing
28. Survival and toxicity of an allogeneic cytokine-secreting fibroblast vaccine in the central nervous system
29. Systemic replacement therapy from genetically modified epidermal keratinocytes
30. Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy
31. Expression of an exogenous growth hormone gene by transplantable human epidermal cells
32. Gene therapy model for stromal precursor cells of hematopoietic microenvironment
33. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors
34. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells
35. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX
36. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
37. Mesenchymal stem cells as vehicles for gene delivery: Transduction of eight species and biodistribution in a canine model
38. Adult mesenchymal stem cells from bone marrow
39. Development of a serum screen for mesenchymal progenitor cells from bone marrow
40. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors
41. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells
42. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
43. Construction of a safe and efficient retrovirus packaging cell line
44. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
45. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
46. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures
47. Quantitative and qualitative analyses of proteoglycans in cartilage extracts by precipitation with 1, 9-dimethylmethylene blue
48. The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans
49. Production of type II collagen specific monoclonal antibodies
50. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation
51. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha
52. Modified Mallory aniline blue stain for bone, cartilage, and other connective tissues
53. Lymphocytes as cellular vehicles for gene therapy in mouse and man
54. Lymphocyte gene therapy
55. In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys
56. Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man
57. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer
58. Human gene therapy
59. Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: Demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1
60. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells
61. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes
62. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope
63. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor
64. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation
65. Improved methods of retroviral vector transduction and production for gene therapy
66. + progenitor cells using retroviral vectors produced by a canine packaging cell line
67. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy
68. Cell-surface receptors for retroviruses and implications for gene transfer
69. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells
70. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
71. Transcriptional silencing of retroviral vectors
72. + cells
73. Manipulation of the hematopoietic stem cell in vitro
74. Erythropoietic repopulating ability of stem cells from long-term marrow culture